Among the biomarkers analyzed, p-Tau variants (e.g., p-Tau181 and p-Tau217) demonstrated superior diagnostic accuracy, reflecting their strong association with AD-specific pathological changes. The gene discussed is MAPT; the disease is Alzheimer disease.